Intuitive Narrows 2026 Procedure Outlook
Intuitive Surgical narrowed its 2026 forecast for da Vinci robotic surgery procedures toward the midpoint of its previous range. The medical device maker posted better third quarter profit and revenue than expected, though its shares declined in extended trading.
Xurve View
Insights:
Xurve View
INTUITIVE SURGICAL INC narrowed its 2026 procedure growth forecast on Tuesday evening, sending shares down 7% in extended trading. The medical-device maker expects worldwide da Vinci procedure growth closer to the midpoint of its 14% to 15% range. Procedure growth drives recurring sales of instruments and accessories, representing its largest revenue segment.
